Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the clinical efficacy of Levetiracetam in the
treatment of symptoms of premenstrual dysphoric disorder (PMDD) in an open label study.